Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Facility will produce biopharmaceutical test samples for all clinical phases
Subscribe to our email newsletter
Richter-Helm BioLogics has completed the modernisation of it´s GMP-production facility in Hannover. Richter-Helm produces recombinant proteins, plasmid DNA and vaccines for biopharmaceuticals.
The company said that the production capacity for fermentation volume and corresponding down-stream capacity for the production of recombinant proteins, plasmid DNA and vaccines deriving from microbial fermentation is now available at the Hannover location.
The new facility is presently undergoing qualification operations. The company has now clean rooms of class D up to class A in B available at the Hannover location, which where designed and constructed following a GMP room concept.
The company said that the new facility is planned for production of biopharmaceutical test samples for all clinical phases, and the facility is also suitable for market supply. The company claims that the two bacterial vaccines which are approved and available at the market were produced at this site.
According to the company the new facility now closes the gap between Richter-Helm’s research facility and the large scale production in Bovenau near Kiel.
The company claims that it has now all common fermentation scales up to 1500L available for GMP production at three different locations.